Quick Take: Numinus Wellness Inc. has harvested the first legal flush of Psilocybe mushrooms in Canada by a public company under its Health Canada-issued Controlled Drugs and Substances Dealer's Licence. VANCOUVER, BC, Oct. 22, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (NUMI), a company creating an ecosystem of health solutions centred on … [Read more...] about Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms
Psychedelics press releases from companies in the industry. Have something to announce? Publish your company news here!
Quick Take: Pharmather Inc. announced it has filed an application with the U.S. FDA to receive Orphan Drug Designation for ketamineThe ketamine will be used in the treatment of levodopa-induced dyskinesia associated with Parkinson’s Disease Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (PHRM) and a specialty … [Read more...] about Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease
Quick Take: Revive Therapeutics Ltd. announced it has signed an agreement with Havn Life Sciences Inc. to source naturally-derived psychedelic compounds for use in future investigational new drugs.The drug will help with enabling studies and clinical trials under the Food and Drug Administration (“FDA”) guidelines. TORONTO, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Revive … [Read more...] about Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds
Quick Take: Cybin and Clarmin announced the closing of a private placement offering of an aggregate of 60M subscription receipts at a price of CDN$0.75 per subscription receipt for proceeds of CDN$45M.Stifel GMP and Eight Capital served as co-lead agents on behalf of a syndicate of agents. TORONTO, Oct. 19, 2020 (GLOBE NEWSWIRE) -- CLARMIN EXPLORATIONS INC. (TSXV: CX.V) … [Read more...] about Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO
Quick Take: Mind Medicine (MindMed) Inc. announced that it has filed a preliminary short form prospectus with the securities commissions or similar authorities in each province of Canada, other than Québec.Canaccord Genuity Corp. has agreed to purchase 23,810,000 units of the company at a price per unit of CAD$1.05 for gross proceeds of CAD$25,000,500. TORONTO, Oct. 16, … [Read more...] about MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing